Apricus Biosciences, Inc. (NASDAQ:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, on 10 November 2014 provided a corporate update and reported financial results for the third quarter 2014. The Company reported total revenues of $1.9 million for the three-month period ended September 30, 2014 related to the recognition of $1.0 million in-license revenues associated with the out-licensing of Vitaros in France, Monaco and certain countries in Africa to Laboratoires Majorelle, a $0.5 million milestone payment from Hexal AG (Sandoz) for the launch of Vitaros in Sweden, and $0.4 million for the initial revenues from the sale of Vitaros product to the Company’s licensee partners. Net loss for the third quarter ended September 30, 2014 was $3.1 million, or $(0.08) per share, compared to a net loss of $3.0 million, or $(0.08) per share for the third quarter ended September 30, 2013. Apricus Biosciences, Inc. (NASDAQ:APRI) belongs to Healthcare sector. Its net profit margin is -75.30% and weekly performance is 3.79%. On last trading day company shares ended up $1.37. Apricus Biosciences, Inc. (NASDAQ:APRI) distance from 50-day simple moving average (SMA50) is -9.09%.
Caterpillar Inc. (NYSE:CAT) has launched the newest addition to its repertoire, the massive 994K Wheel Loader. The wheel loader, which is Cat’s largest to date, features increased payload, versatility, power and productivity and a number of efficiency improvements. Caterpillar Inc. (NYSE:CAT) shares increased 4.27% in last trading session and ended the day at $106.45. CAT Gross Margin is 26.90% and its return on assets is 4.60%. Caterpillar Inc. (NYSE:CAT) quarterly performance is -0.65%.
American Airlines Group Inc (NASDAQ:AAL) subsidiary Envoy Air plans to transfer at least 50 Embraer 145 aircraft to other regional carriers beginning in early 2015 in a move that will lead to job cuts, according to an internal letter reviewed by NEWS.GNOM.ES. On 21 November, American Airlines Group Inc. (NASDAQ:AAL) shares fell -1.92% and was closed at $43.31. AAL EPS growth in last 5 year was -6.60%. American Airlines Group Inc. (NASDAQ:AAL) year to date (YTD) performance is 72.41%.
BioDelivery Sciences International (NASDAQ:BDSI) Director William B. Stone sold 14,000 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $16.11, for a total value of $225,540.00. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) ended the last trading day at $14.29. Company weekly volatility is calculated as 3.74% and price to cash ratio as 8.54. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) showed a weekly performance of -1.24%.
Fuel Systems Solutions (NASDAQ:FSYS) last released its earnings data on Monday, August 18th. The company reported ($0.05) earnings per share for the quarter, missing the analysts’ consensus estimate of $0.02 by $0.07. The company had revenue of $87.40 million for the quarter, compared to the consensus estimate of $89.53 million. During the same quarter last year, the company posted $0.13 earnings per share. Fuel Systems Solutions’s revenue was down 30.9% compared to the same quarter last year. On average, analysts expect Fuel Systems Solutions to post $-0.51 EPS for the current fiscal year and $-0.03 EPS for the next fiscal year. Fuel Systems Solutions, Inc. (NASDAQ:FSYS) shares fell -0.58% in last trading session and ended the day at $10.33. FSYS Gross Margin is 21.00% and its return on assets is -13.80%. Fuel Systems Solutions, Inc. (NASDAQ:FSYS) quarterly performance is 4.34%.